N/A
N=144
Home Exercise to Enhance Mobility for Older Diabetics
Diabetes Mellitus Type 2
Bottom Line
View on ClinicalTrials.gov: NCT01308008 ↗Enrolled (actual)
144
Serious AEs
4.2%
Results posted
Nov 2018
Primary outcome: Primary: Comfortable Gait Speed — 1.2; 1.2 meters per second — p=0.16
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- home exercise/physical activity (PA) enhancement program with behavioral support (Behavioral); flex and toning health education program (Behavioral)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- May 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Comfortable Gait Speed |
1.2; 1.2 | 0.16 |
| PRIMARY Six Minute Walk Distance |
1307; 1271 | 0.17 |
| SECONDARY Physical Activity |
170; 141 | 0.5 |
Summary
The goal of the proposed research is to test whether a long-term exercise program in sedentary Veterans with diabetes will produce sustained improvement in mobility performance and physical activity. In this proposed research, 240 sedentary older adult diabetics (aged 60 and over) will be randomly allocated into a customized, primarily home-based, functionally-oriented exercise program with nurse support intervention (I) group versus a flexibility and toning, health education control (C) group, and test outcomes in functional mobility and physical activity at 4 weeks, 6 months and one year. This research can lead to an exercise/PA enhancement program that can coordinate with VA outreach programs, targeting older Veterans who are not in the immediate vicinity of a major VA site. Ultimately, this should create a model to which physicians and other providers could refer comorbid diabetes patients.
Eligibility Criteria
Inclusion Criteria
- Sedentary
- Type 2 Diabetes
- No medical contraindications to exercise
Exclusion Criteria
- Enrolled in intensive exercise program
- Unable to cooperate with protocol (e.g. cognitive impairment)
Data sourced from ClinicalTrials.gov (NCT01308008). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.